STING1 and neoplasm: Major mechanisms will be covered, including (1) the cGAS‐STING‐IFN‐I axis, a critical pathway associated with sensing nucleic acids to activate immune response; (2) improvements in tumor immunogenicity; (3) stimulation of immune effector cells; and (4) modulation of the tumor microenvironment.